International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

Latin America Virtual Masterclass

Course Overview

The IPC Psoriasis Masterclass is designed for dermatologists who are making treatment decisions and managing patients with psoriasis and are interested in specializing in psoriasis.

Over the five days of the course, IPC’s world-renowned experts will cover a variety of topics including the pathogenesis of psoriasis, new and emerging therapies and how to be an advocate for your patient.

The Masterclass agenda has been carefully developed to provide knowledge for daily use to the practicing dermatologist in an intimate environment designed to maximize faculty/participant interactions. Through lectures, panels, case-based discussions and question-answer sessions, attendees will obtain practical and important information for their dermatology practice.

The IPC Masterclass is open to dermatologists and general practitioners who meet the following criteria:

  • A diploma, 1st part MSc or higher degree in internal medicine or dermatology
  • Practicing internal medicine or dermatology within a governmental establishment i.e. university hospital, public hospitals, rural hospitals, etc.
  • At least 3 years of practice

There is no cost to attend the program, but space is limited. The application deadline is May 22, 2023.

Timezones:
Tijuana: 11:00 – 1:00 pm (UTC -7)
Mexico City / Guatemala City / Juarez: 12:00 – 2:00 pm (UTC -6)
Bogota / Lima / Panama: 1:00 – 3:00 pm (UTC -5)
Santiago / Asunción / Santiago de los Caballeros: 2:00 – 4:00 pm (UTC -4)
Buenos Aires / São Paulo: 3:00 – 5:00 pm (UTC -3)

Agendas

WELCOME + INTRODUCTION 

Clinical Manifestations of Psoriasis

Recategorization of Psoriasis Severity

Global Psoriasis Atlas

Patient Perspectives

Clinical Cases

CLOSING COMMENTS

WELCOME + INTRODUCTION

Updates in Pathophysiology & Genetics


Psoriasis in Special Areas


Updates on Comorbidities


Updates on Psoriatic Arthritis


Clinical Cases


CLOSING COMMENTS

WELCOME + INTRODUCTION

Pediatric Psoriasis


Generalized Pustular Psoriasis


Treat to Target


Topical Therapies and Phototherapy


Methotrexate


Clinical Cases


CLOSING COMMENTS

WELCOME + INTRODUCTION

Screening and Monitorization of Biologics


Anti TNF-a


Anti IL 17, Anti IL12/23 and Anti IL-23


New Oral Therapies


Clinical Cases


CLOSING COMMENTS

WELCOME + INTRODUCTION

Biosimilars


Personalized Treatment


Biomarkers in Psoriasis

My Challenging Cases

Clinical Cases

CLOSING COMMENTS

Program Co-Chairs

Claudia de la Cruz, MD

Clinica Dermacross

Santiago, Chile

Secretary

Bio

André Carvalho, MD, PhD

Hospital Moinhos de Vento

Porto Alegre, Brazil

Bio

Daniela Armijo, MD

Clínica Dermacross

Santiago, Chile

Bio